"The next ten years will be the rapid development of China's pharmaceutical industry、Fully integrated gold ten years，For the new medicine，The key is the first three years of the golden decade。"This is Lu Mingfang, chairman of Shang Pharmaceutical Group Lu Mingfang's judgment of the development of the Chinese pharmaceutical industry and its own strategic assessment，From the current competitive situation of the pharmaceutical stake online sports bettingindustry，stake online sports bettingThis should also be the consensus of the three major pharmaceutical giants in China。 
However, in recent months，Slowly China Resources Pharmaceutical Action，The pharmaceutical industry only see the dragon and tiger fight between the Chinese medicine and the medicine，No real "Three Kingdoms Romance"。
Shanghai Pharmaceutical (601607) After completing the overall listing of A shares，It is also intended to imitate the Pharmaceutical Boss National Medicine Group，Going to Hong Kong listing and financing 8 billion yuan mergers and acquisitions，Create the strongest core competitiveness in China、Large -scale pharmaceutical group covering the entire industry chain。
Sinopharm Group, which has a leading advantage in pharmaceutical commerce, has also worked hard to expand in the pharmaceutical industry recently。On September 8th, the Sinopharm Group and the Shenzhen Municipal Government officially signed a strategic cooperation framework agreement，Both parties will cooperate in multiple fields such as biopharmaceuticals，This is another major measure after the successful mergers and acquisition of Zhongsheng Group and the Shanghai Medical College after the successful merger。Through this cooperation，Sinopharm Group will advance to China Resources Pharmaceutical's base camp Shenzhen。
Compared with the aggressive Stake Sports BettingMy stake betting appdevelopment pace of Chinese medicine and medicine，The development process of China Resources Pharmaceutical has been quite slow in the past six months。Although at the end of July, the Beijing Municipal Government officially signed the "Reorganization Agreement on Beijing Pharmaceutical Group Co., Ltd. and China Resources Pharmaceutical Group Co., Ltd.，But the specific content, including equity ratio and payment titles, has not been announced。and Chinese medicine、Apply the medicine comparison，China Resources Pharmaceutical not only does not have the advantages of medical business，In the field of biomedicine, which is planned to develop in Beijing,，It will also face the strong competition of China Biotechnology Group, a subsidiary of Chinese Medicine。
Although China Resources is known for its mergers and acquisitions, it is named in the industry，Li Fuxi, who has recently served as CEO of China Resources Pharmaceutical, was the strategic director of China Resources Group and general manager of the strategic management department of China Resources Group，Many M & A and reorganizations under China Resources are mostly operated by them，But Chinese medicine and medicine are not inferior in this area。Song Zhiping, Chairman of Chinese Medicine, is the only capital reorganization My stake betting appstake sports betting appmaster of the two major central enterprises of China Building Materials and Sinopharm Group at the same time as the central enterprise.，Chairman of the Medicine Lu Mingfang is also a veteran of the capital market，Before joining Shangshi Group，Once at the Bank of Communications Shanghai Branch、Shanghai Wanuo Securities Company workers，After joining Shangshi Group，Sooned to Hong Kong，Host the various businesses of Shangshi Holdings，After being recalled to host the reorganization of the new medicine。
Not only that，China Resources enters the pharmaceutical industry，It has only 10 years so far，and the Chinese medicine and medicine starting with medicine，I have accumulated for decades in the pharmaceutical industry，More advantages in the effective combination of professional literacy and capital operation level。
but，China Resources Group passed the mergers and acquisitions of the well -known snowflake beer，After 16 years of operation and operation，Make it a successful case of the largest domestic beer company in China，Allows the industry to enter the pharmaceutical industry，Become "the most scale and influence in China's life and health industry、The ambition of the most trustworthy pharmaceutical group in Volkswagen and the government "has high hopes，I hope it will not stake sports betting appstake betting apprepeat the mistakes that previously cooperated with local state -owned assets。